Case Report
Version 1
Preserved in Portico This version is not peer-reviewed
Peri-Implantitis - Decontaminating and Regenerative Treatment Protocol
Version 1
: Received: 23 December 2020 / Approved: 23 December 2020 / Online: 23 December 2020 (16:12:26 CET)
How to cite: Duarte, F.; De Oliveira, L. Peri-Implantitis - Decontaminating and Regenerative Treatment Protocol. Preprints 2020, 2020120597. https://doi.org/10.20944/preprints202012.0597.v1 Duarte, F.; De Oliveira, L. Peri-Implantitis - Decontaminating and Regenerative Treatment Protocol. Preprints 2020, 2020120597. https://doi.org/10.20944/preprints202012.0597.v1
Abstract
Peri-implant diseases are defined as pathological inflammatory reactions in the tissue surrounding the osseointegrated implants. They are classified into two categories: mucositis - defined as peri-implant soft tissue inflammation and peri-implantitis - bone loss in the peri-implant region. A clinical case of a 61-years-old woman with an implant in the 46 anatomical position and a 5-year follow-up is presented. A probe depth of 5mm and a bone defect length of 35% was observed. The Implacure® Protocol was applied, with the main objective of eliminating the biofilm present on the exposed implant surface. There are multiple approaches to treat peri-implant diseases. While non-surgical treatment is essential for mucositis control, the treatment of peri-implantitis surgical treatment should be considered. Regenerative bone reconstruction promotes bone repair in the defect area and reduces bleeding during probing. To achieve that, autologous fibrin combined with Cerasorb M® was used. The proposed approach in the exposed clinical case involves the application of Implacure® Protocol, whose combination of the physical decontamination technique, together with the use of chlorhexidine and orthophosphoric acid, added with the combination Piperacillin + Tazobactam together with hyaluronic acid, provide a base that allows to regenerate bone using platelet-rich fibrin with Cerasorb M® and increase the survival time of the implant.
Keywords
Peri-implantitis; Implacure® Protocol; Platelet-rich Fibrin
Subject
Medicine and Pharmacology, Clinical Medicine
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment